Your browser doesn't support javascript.
loading
The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.
Ahmad, Shamaila Munir; Martinenaite, Evelina; Holmström, Morten; Jørgensen, Mia Aaboe; Met, Özcan; Nastasi, Claudia; Klausen, Uffe; Donia, Marco; Pedersen, Lars Møller; Munksgaard, Lars; Ødum, Niels; Woetmann, Anders; Svane, Inge Marie; Andersen, Mads Hald.
Afiliação
  • Ahmad SM; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Martinenaite E; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Holmström M; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Jørgensen MA; Department of Hematology, Zealand University Hospital, DK-4000 Roskilde, Denmark.
  • Met Ö; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Nastasi C; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Klausen U; Department of Oncology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Donia M; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Pedersen LM; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Munksgaard L; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Ødum N; Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Woetmann A; Department of Oncology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Svane IM; Department of hematology, Copenhagen University Hospital, Herlev, DK-2730 Herlev, Denmark.
  • Andersen MH; Department of Hematology, Zealand University Hospital, DK-4000 Roskilde, Denmark.
Oncoimmunology ; 7(2): e1390641, 2018.
Article em En | MEDLINE | ID: mdl-29308318
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Dinamarca